BMI1 and colorectal cancer: In another study, exosome-mediated miR-128-3p delivery was demonstrated to inhibit oxaliplatin-induced epithelial–mesenchymal transition (EMT) and enhanced oxaliplatin response through negative regulation of Bmi1 and MRP5 in colorectal cancer cells (23).